A comprehensive analysis of serum D-dimer and Ferritin levels, in 347 patients with severe (breathlessness and chest discomfort) corona virus disease 2019

Sudharani Jangamgudem


Background: This study aimed to evaluate the association between serum D-dimer and Ferritin levels, in patients with severe (Breathlessness and chest discomfort) corona virus disease 2019.

Methods:  The present study included a 347 (out of 1500) patients with severe Breathlessness and Chest discomfort age between 40 to 60 years who were confirmed to have Covid-19 based on RTPCR in a GVPIHC&MT referral hospital between 2020 June and 2020 August, were analysed.

Results:  A total No of 694 cases were studied by dividing them into two groups controls 347 and cases 347. The results so obtained compare with 347 healthy controls included in this study.  Statistical evaluation was carried out to confirm any deviation from the normal values.  The Mean± SD Serum FERRITIN Cases (654.45±317.45), controls (157.03±87.43), D-dimer values of cases (6.1517±3.4270), controls (0.2204±0.1083) and both serum Ferritin and D-dimer values in cases (3.443230±3.625471), controls (0.201372±0.121560). This increase is statistically P value highly significant (<0.001)

Conclusions:  It has been shown from this study with, the serum activities of D-Dimer and Ferritin levels were markedly increased in Severe Breathlessness and Chest discomfort in male and female COVID-19 patients.  


Corona, Breathlessness and chest discomfort, D-dimer and ferritin

Full Text:



Page J, Hinshaw D, McKay B. "In Hunt for Covid-19 Origin, Patient Zero Points to Second Wuhan Market – The man with the first confirmed infection of the new coronavirus told the WHO team that his parents had shopped there". The Wall Street Journal. Accessed on 27 February 2021.

Zimmer C. The Secret Life of a Coronavirus – An oily, 100-nanometer-wide bubble of genes has killed more than two million people and reshaped the world. Scientists don't quite know what to make of it. 2021. Accessed on 28 February 2021.

Symptoms of Coronavirus. U.S. Centers for Disease Control and Prevention (CDC). 2021. Accessed on 4 March 2021.

Grant MC, Geoghegan L, Arbyn M, Mohammed Z, McGuinness L, Clarke EL et al. The prevalence of symptoms in 24,410 adults infected by the novel coronavirus (SARS-CoV-2; COVID-19): A systematic review and meta-analysis of 148 studies from 9 countries". PLOS ONE. 2021;15(6).

Islam MA. Prevalence of Headache in Patients With Coronavirus Disease 2019 (COVID-19): A Systematic Review and Meta-Analysis of 14,275 Patients. Frontiers in Neurology. 2020;1-9.

Saniasiaya J, Islam MA. Prevalence of Olfactory Dysfunction in Coronavirus Disease 2019 (COVID-19): A Meta-analysis of 27,492 Patient. The Laryngoscope. 2021;865-78.

Saniasiaya J, Islam MA. Prevalence and Characteristics of Taste Disorders in Cases of COVID-19: A Meta-analysis of 29,349 Patients. Otolaryngology–Head and Neck Surgery. 2020;1-10.

Islam MA. Prevalence and characteristics of fever in adult and paediatric patients with coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis of 17515patients. PLOSONE. 2020;e0249788.

Clinical characteristics of COVID-19. European Centre for Disease Prevention and Control. Accessed on 29 December 2020.

Pranata R, Huang I, Lukito AA. Elevated N-terminal pro-brain natriuretic peptide is associated with increased mortality in patients with COVID-19: systematic review and meta-analysis. Postgrad Med J. 2020;137884.

Huang I, Lim MA, Pranata R. Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia – a systematic review, meta-analysis, and meta-regression: diabetes and COVID-19. Diabetes Metab Syndr Clin Res Rev. 2020;14:395-403.

Pranata R, Huang I, Lim MA. Impact of cerebrovascular and cardiovascular diseases on mortality and severity of COVID-19 – systematic review, meta-analysis, and meta-regression. J Stroke Cerebrovasc Dis. 2020;29:104949.

Huang I, Pranata R. Lymphopenia in severe coronavirus disease-2019 (COVID-19): systematic review and meta-analysis. J Intensive Care. 2020;8:36.

Mehta P, McAuley DF, Brown M. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395:1033-4.

Adam SS, Key NS, Greenberg CS. "D-dimer antigen: current concepts and future prospects". Blood. 2009;113(13):2878-87.

Rowbotham BJ, Carroll P, Whitaker AN, Bunce IH, Cobcroft RG, Elms MJ et al. Measurement of cross-linked fibrin derivatives - use in the diagnosis of venous thrombosis. Thromb Haemost. 1987;57:59-61.

Bounameaux H, Schneider PA, Reber G, de Moerloose P, Krahenbuhl B. Measurement of plasma D-dimer for diagnosis of deep venous thrombosis. Am J Clin Pathol. 1989;91:82-5.

Ginsberg JS, Brill-Edwards PA, Demers C, Donovan D, Panju A. D-dimer in patients with clinically suspected pulmonary embolism. Chest. 1993;104:1679-84.

Heinrich J, Schulte H, Scho¨ nfeld R, Ko¨ hler E, Assmann G. Association of variables of coagulation, fibrinolysis and acute-phase with atherosclerosis in coronary and peripheral arteries and those arteries supplying the brain. Thromb Haemost. 1995;73:374-9.

Salomaa V, Stinson V, Kark JD, Folsom AR, Davis CE, Wu KK. Association of fibrinolytic parameters with early atherosclerosis. The ARIC Study.Atherosclerosis Risk in Communities Study. Circulation. 1995;91:284-90.

Carey MJ, Rodgers GM. Disseminated intravascular coagulation: clinical and laboratory aspects. Am J Hematol. 1998;59:65-73.

Angstwurm MW, Dempfle CE, Spannagl M. New disseminated intravascular coagulation score: A useful tool to predict mortality in comparison with Acute Physiology and Chronic Health Evaluation II and Logistic Organ Dysfunction scores. Crit Care Med. 2006;34:314-20.

Hesselvik JF, Blomba¨ck M, Brodin B, Maller R. Coagulation, fibrinolysis, and kallikrein systems in sepsis: relation to outcome. Crit Care Med. 1989;17:724-33.

Gando S, Nanzaki S, Sasaki S, Aoi K, Kemmotsu O. Activation of the extrinsic coagulation pathway in patients with severe sepsis and septic shock. Crit Care Med. 1998;26:2005-9.

Rocha E, Pa´ramo JA, Ferna´ndez FJ, Cuesta B, Herna´ndez M, Paloma MJ, et al. Clotting activation and impairment of fibrinolysis in malignancy. Thromb Res. 1989;54:699-707.

Bongard O, Wicky J, Peter R, Simonovska S, Vogel JJ, de Moerloose P, et al. D-dimer plasma measurement in patients undergoing major hip surgery:use in the prediction and diagnosis of postoperative proximal vein thrombosis. Thromb Res. 1994;74:487-93.

Tasic N, Paixao T, Goncalves L. Biosensing of D-dimer, making the transition from the central hospital laboratory to bedside determination. Talanta. 2020;207(2):120270.

Linkins LA, Lapner TS. Review of D-dimer testing: good, bad, and ugly. Int J Lab Hematol. 2017;39(S1):98-103.

Lippi G, Bonfanti L, Saccenti C, Cervellin G. Causes of elevated D-dimer in patients admitted to a large urban emergency department. Eur J Intern Med. 2014;25(1):45-8.

Ruddell RG, Hoang-Le D, Barwood JM. Ferritin functions as a pro-inflammatory cytokine via ironindependent protein kinase C zeta/ nuclear factor kappaB-regulated signaling in rat hepatic stellate cells. Hepatology. 2009;49:887-900.

Chen G, Wu D, Guo W. Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Investig. 2020;130(5):2620-9.

Giamarellos-Bourboulis EJ, Netea MG, Rovina N. Complex immune dysregulation in COVID-19 patients with severe respiratory failure. BMJ Open Diabetes Res Care. 2020;27(6):992-1000.

Li Y, Hu Y, Yu J, Ma T. Retrospective analysis of laboratory testing in 54 patients with severe- or critical-type 2019 novel coronavirus pneumonia. Lab Investig. 2020;100:794-800.

Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020;46(5):846-8.

Sun L, Shen L, Fan J. Clinical features of patients with coronavirus disease 2019 (COVID-19) from a designated hospital in Beijing, China. Pediatr Allergy Immunol. 2020;110:14-22.

Wang F, Hou H, Luo Y. The laboratory tests and host immunity of COVID-19 patients with different severity of illness. JCI insight. 2020;5:e137799.

Zhou F, Yu T, Du R. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054-62.

Renfei Lu, Jianru Qin, Yan Wu. Epidemiological and clinical characteristics of COVID-19 patients in Nantong, China. J Infect Dev Ctries. 2020;14:440-6.

Kell DB, Pretorius E. Serum ferritin is an important inflammatory disease marker, as it is mainly a leakage product from damaged cells. Metallomics. 2014;6(4):748-73.

Kno-vich MA, Storey JA, Coffman LG, Torti SV, Torti FM. Ferritin for the clinician. Blood Rev. 2009;23(3):95-104.

Cortese-Krott MM, Koning A, Kuhnle GGC, Nagy P, Bianco CL, Pasch A, et al. The reactive species interactome: evolutionary emergence, biological significance, and opportunities for redox metabolomics and personalized medicine. Antioxid Redox Signal. 2017;27(10):684-712.